Meet a Guru: Erica Loring

Global Medical Device Podcast · 28 Oct 2020 · 38m · Episode 165

What this episode covers

Erica Loring, a medical device guru at Greenlight Guru, discusses her background in pharmaceuticals and IVDs, emphasizing the critical distinction between Quality Assurance and Regulatory Affairs. She explains how the 'throw it over the wall' mentality creates documentation gaps and costly remediation, advocating for cross-functional collaboration from concept to market. Loring highlights the importance of investing in people, allowing adequate time for development, and rigorously auditing suppliers to ensure successful product launches.

Mentioned

Companies
Greenlight Guru, Lonza Biologics, Cook Medical, Master Control, Breathe 99, Masks On
Also
FDA, ISO 13485, 510(k), EUA

Other shows on the same ground, closest first.

  • Let's Combinate · 1h 19m

    031 - "The Five Stages Of Regulatory Grief" with Michelle Lott

    Michelle Lott, founder of Lean RAQA, discusses her journey from large manufacturer Baxter Healthcare to consulting for small-to-mid-size medical device companies, highlighting the gap in practical regulatory strategy. She details the 'five stages of regulatory grief' clients experience when facing FDA interactions, contrasting the US 510(k) process with the rigorous, ongoing costs of EU MDR compliance. Lott also explains the nuances of regulations versus guidance documents, the QMSR harmonization, and her unique perspective as an elected industry representative on the FDA Device GMP Advisory Committee.

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

  • Let's Combinate · 55m

    066 -Scientist to CSO, Learning QA/RA & Marketing, and Saying Yes to Oppurtunities with Fran DeGrazio

    Fran DeGrazio, President of Strategic Parenteral Solutions and former Chief Scientific Officer at West Pharmaceuticals, discusses the complexities of combination products, highlighting the historical silos between science and engineering. She explains how regulatory frameworks like ICH Q8-Q10 and Quality by Design (QbD) have shifted the industry toward risk management and lifecycle management, which she identifies as a major struggle for smaller organizations. DeGrazio also shares her career trajectory at West, detailing her transition from laboratory roles to leading Quality, Regulatory, and Marketing, emphasizing the importance of strategic execution and continuous learning.

  • Let's Combinate · 19m

    210 - The 8 Roles You MUST Understand in Pharma & MedTech

    Subhi Saadeh, host of Let's Combinate and a quality professional with experience in large medical device and pharma organizations, explains eight core functional roles in life sciences companies. She details the responsibilities of Quality Assurance, Regulatory Affairs, Research & Development, Clinical Affairs, Manufacturing, Quality Control, Supply Chain, and Validation to help early-career professionals navigate career paths. Saadeh emphasizes that understanding these cross-functional interactions is critical for success, drawing on her own journey from struggling in R&D to finding a fit in Quality.

    1 chapters
  • Let's Combinate · 8m

    244 - 5 Critical Quality Differences Between Drugs and Devices

    Subhi Saadeh, a consultant specializing in drug-device combination products, explains five critical quality differences between pharmaceuticals and medical devices. He contrasts the drug industry's focus on consistent manufacturing of clinically proven products (ICH Q8/Q9) with the device industry's emphasis on design robustness and user needs (ISO 13485/14971). The discussion covers divergent approaches to risk management, regulatory submission evidence, and lifecycle change control, urging teams to intentionally integrate these systems rather than forcing one onto the other.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.